Curvilinearity in the dose-response curve for cancer in Japanese atomic bomb survivors.

Recently released data on cancer incidence in Japanese atomic bomb survivors are analyzed using a variety of relative risk models that take account of errors in estimates of dose to assess the dose response at low doses. If a relative risk model with a threshold (the dose response is assumed linear above the threshold) is fitted to solid cancer data, a threshold of more than about 0.2 Sv is inconsistent with the data, whereas these data are consistent with there being no threshold. Among solid cancer subtypes there is strong evidence for a possible dose threshold only for nonmelanoma skin cancer. If a relative risk model with a threshold (the dose response is assumed linear above the threshold) is fitted to the leukemia data, a threshold of more than about 0.3 Sv is inconsistent with the data. In contrast to the estimates for the threshold level for solid cancer data, the best estimate for the threshold level in the leukemia data is significantly different from zero even when allowance is made for a possible quadratic term in the dose response, albeit at borderline levels of statistical significance (p = 0.04). There is little evidence for curvature in the leukemia dose response from 0.2 Sv upwards. However, possible underestimation of the errors in the estimates of the dose threshold as a result of confounding and uncertainties not taken into account in the analysis, together with the lack of biological plausibility of a threshold, makes interpretation of this finding questionable.

[1]  D. Pierce,et al.  Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. , 1995, Journal of the National Cancer Institute.

[2]  E Cardis,et al.  Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. , 1995, Radiation research.

[3]  T. Aoyama,et al.  Radon concentrations in residential housing in Hiroshima and Nagasaki. , 1995, Health physics.

[4]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[5]  D. Preston,et al.  Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. , 1994, Radiation research.

[6]  H. Dohy,et al.  Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. , 1994, Radiation research.

[7]  John A. Nelder,et al.  Generalized linear models. 2nd ed. , 1993 .

[8]  M. Little.  Risks of radiation-induced cancer at high doses and dose rates , 1993 .

[9]  W. A. Woolson,et al.  Neutron discrepancies in the DS86 Hiroshima dosimetry system. , 1992, Health physics.

[10]  D. Lloyd,et al.  Chromosomal aberrations in human lymphocytes induced in vitro by very low doses of X-rays. , 1992, International journal of radiation biology.

[11]  S. Sawada,et al.  Organ doses received by atomic bomb survivors during radiological examinations at the Radiation Effects Research Foundation. , 1991, The British journal of radiology.

[12]  D. Pierce,et al.  The shape of the cancer mortality dose-response curve for the A-bomb survivors. , 1991, Radiation research.

[13]  D. Pierce,et al.  Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. , 1990, Radiation research.

[14]  H. Kato,et al.  Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86). , 1990, Radiation research.

[15]  D. Goodhead,et al.  Track structure analysis of ultrasoft X-rays compared to high- and low-LET radiations. , 1989, International journal of radiation biology.

[16]  L. Ayvazian,et al.  Health Risks of Radon and Other Internally Deposited Alpha-Emitters (Beir IV) , 1988 .

[17]  D L Preston,et al.  Studies of the mortality of A-bomb survivors. 8. Cancer mortality, 1950-1982. , 1987, Radiation research.

[18]  E. Gilbert.  Some effects of random dose measurement errors on analyses of atomic bomb survivor data. , 1984, Radiation research.

[19]  N. Bianchi,et al.  Effect of low-dose acute X-irradiation on the frequencies of chromosomal aberrations in human peripheral lymphocytes in vitro. , 1983, Mutation research.

[20]  D. Papworth,et al.  The dose-response for x-ray induction of myeloid leukaemia in male CBA/H mice. , 1983, British Journal of Cancer.

[21]  H. F. Lucas,et al.  Dose-response relationships for female radium dial workers. , 1978, Radiation research.

[22]  A. Stewart,et al.  Age variation in the cancer risks from foetal irradiation. , 1977, British Journal of Cancer.

[23]  R. Sievert,et al.  Book Reviews : Recommendations of the International Commission on Radiological Protection (as amended 1959 and revised 1962). I.C.R.P. Publication 6. 70 pp. PERGAMON PRESS. Oxford, London and New York, 1964. £1 5s. 0d. [TB/54] , 1964 .

[24]  C R Muirhead,et al.  Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors. , 1996, International journal of radiation biology.

[25]  F. Y. Edgeworth,et al.  The theory of statistics , 1996 .

[26]  D T Goodhead,et al.  Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. , 1994, International journal of radiation biology.

[27]  W. Schull,et al.  Radiation-related small head sizes among prenatally exposed A-bomb survivors. , 1993, International journal of radiation biology.

[28]  J. Thacker.  Radiation-Induced Mutation in Mammalian Cells at Low Doses and Dose Rates , 1992 .

[29]  Icrp.  1990 Recommendations of the International Commission on Radiological Protection , 1991 .

[30]  D. Papworth,et al.  Dose-response models for the radiation-induction of skin tumours in mice. , 1983, International journal of radiation biology and related studies in physics, chemistry, and medicine.